This series re-examines the concurrent controversies at the Cancer Prevention and Research Institute of Texas and MD Anderson Cancer Center. This examination is possible in part because of new insight provided by Alfred Gilman, the Nobel laureate who served as the first scientific director of the state institution that distributes $300 million a year. Gilman died on Dec. 23, 2015.
HARVARD BUSINESS SCHOOL's Health Care Initiative launched the Precision Trials Challenge, a competition to bring precision diagnostics and therapies to market more quickly.
UC SAN DIEGO HEALTH selected e+CancerCare, a national operator of outpatient cancer care centers, to operate the UC San Diego Health - Chula Vista radiation oncology facility.
Over the past century, we have had many wars on cancer, and now we have a national “moonshot” to be spearheaded by Vice President Joe Biden, announced in President Barack Obama's Jan. 12 State of the Union Address.
The text of Vice President Joe Biden's Jan. 19 remarks at a World Economic Forum meeting of international cancer experts in Davos-Klosters, Switzerland, follows:
The Obama administration will find the money to create a comprehensive oncology bioinformatics system, Vice President Joe Biden pledged Jan. 19 at a meeting of international cancer experts at the World Economic Forum in Davos-Klosters, Switzerland.
Government agencies said the biotechnology billionaire Patrick Soon-Shiong had overstated the extent of their involvement in “Cancer MoonShot 2020,” the immunotherapy clinical trials program he put together.
Did Patrick Soon-Shiong attempt to scoop President Barack Obama's State of the Union address?
President Barack Obama announced a moonshot aimed at curing cancer, a project to be led by Vice President Joe Biden.
FDA granted Breakthrough Therapy Designation to an epidermal growth factor receptor mutant-specific tyrosine kinase inhibitor, BI 1482694 (HM61713).
